Status:
RECRUITING
Acellular Dermal Matrix vs Autologous Tarsus for Correction of Lower Eyelid Retraction
Lead Sponsor:
Haukeland University Hospital
Conditions:
Lower Eyelid Retraction
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to compare the effectiveness of two promising implants in treatment of lower eyelid retraction in 40 patients. This condition often resulting from injury, surgical c...
Detailed Description
The study aims to find the best way to surgically correct lower eyelid retraction, a condition where the lower eyelid droops, leading to eye dryness, irritation, and potential vision problems. This co...
Eligibility Criteria
Inclusion
- Adult patients aged 18-75 years.
- Grade 2 or higher lower eyelid retraction (according to the retraction grading scale).
- Candidate for surgical correction due to functional or cosmetic reasons.
- Willingness to participate and provide informed consent.
Exclusion
- Active ocular or eyelid infection.
- History of severe scarring or keloid formation.
- Concurrent orbital or eyelid malignancies. Pregnancy or lactation. Uncontrolled systemic diseases (e.g., diabetes, immune disorders). Previous eyelid surgery on the affected eye.
Key Trial Info
Start Date :
January 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2032
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06926686
Start Date
January 1 2025
End Date
January 1 2032
Last Update
April 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Haukeland University Hospital
Bergen, Vetslandet, Norway, 5021